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Background: While commonly used to describe liver resections at risk for post-operative complications,
no standard definition of ‘major hepatectomy’ exists. The objective of the present retrospective study is
to specify the extent of hepatic resection that should describe a major hepatectomy.
Methods: Demographics, diagnoses, surgical treatments and outcomes from patients who underwent a
liver resection at two high-volume centres were reviewed.
Results: From 2002 to 2009, 1670 patients underwent a hepatic resection. Post-operative mortality and
severe, overall and hepatic-related morbidity occurred in 4.4%, 29.7%, 41.6% and 19.3% of all patients.
Mortality (7.4% vs. 2.7% vs. 2.6%) and severe (36.7% vs. 24.7% vs. 24.1%), overall (49.3% vs. 40.6%
vs. 35.9%) and hepatic-related (25.6% vs. 16.4% vs. 15.2%) morbidity were more common after
resection of four or more liver segments compared with after three or after two or fewer segments (all
P < 0.001). There were no significant differences in any post-operative outcome after resection of three
and two or fewer segments (all P > 0.05). On multivariable analysis, resection of four or more liver
segments was independently associated with post-operative mortality and severe, overall, and hepatic-
related morbidity (all P < 0.01).
Conclusions: A major hepatectomy should be defined as resection of four or more liver segments.
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Introduction
While it is widely recognized that the risks of liver resection are
directly related to the volume and function of the liver remnant,
these measures may be difficult to determine pre-operatively and
are widely under reported among studies analysing post-operative
outcomes after liver resection. Hence, most investigators define a
major liver resection by the volume of liver resected. Stratification
by extent of resection has been used to analyse mortality1–17 and
morbidity3–5,11,14,15,17–25 after a partial hepatectomy. In these set-
tings, patients undergoing a major hepatectomy are at the highest
risk of adverse post-operative outcomes. Thus, novel treatments
aimed at improving the overall safety profile of liver resection are
often focused on this subgroup.26–33 Yet no standard definition of a
major hepatectomy exists. Resections of two, three, four or five
liver segments and a hemihepatectomy have been previously used
by us and other investigators as a threshold for a major liver
resection. This inconsistency not only hinders comparisons
between studies, but also hampers an adequate assessment of
morbidity and mortality risk when counselling patients regarding
liver resection. The objective of the present study was to determine
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the extent of resection that should define a major hepatectomy by
reviewing liver resections performed at two high-volume aca-
demic centres during the contemporary era and identifying
those patients at highest risk for post-operative mortality and
morbidity.
Methods
After obtaining approval from the Institutional Review Board at
both institutions, demographics, clinicopathological data, surgical
treatments and post-operative outcomes from patients who
underwent a liver resection at the Liver Cancer Center at the
University of PittsburghMedical Center (UPMC) and at the Duke
University Medical Center (DUMC) were reviewed. Patients
whose only hepatic procedure was a liver biopsy or radiofrequency
ablation were excluded from the present study. Most hepatic
lesions were detected pre-operatively with computed tomography,
magnetic resonance imaging and/or positron emission tomogra-
phy. Intra-operative ultrasonography was used to detect and local-
ize all lesions with respect to major vessels. The extent of hepatic
resection was at the discretion of the operating surgeon with the
aim of achieving negative surgical margins and a liver remnant of
sufficient volume to maintain hepatic function with intact vascu-
lar inflow, vascular outflow and biliary drainage. Hepatic resec-
tions are described using Brisbane 2000 terminology.34 To
determine the extent of resection, wedge resections were counted
as one-half of a segment and the number of resected segments
were rounded down to the nearest whole number. Importantly,
any resections which did not follow anatomic planes were catego-
rized as wedge resections. The volume of liver resected itself was
not used to distinguish wedge and anatomic resections. Ninety-
day post-operative morbidity and mortality were recorded.
Post-operative complications were graded according to the
Dindo–Clavien classification35 with the following exceptions: (i)
grade I complications were largely not recorded except for wound
infection and ascites requiring diuresis and (ii) the need for a
blood transfusion was not regarded as a complication. Complica-
tions grade III and above were considered severe. Hepatic-related
morbidity included hepatic abscess or fluid collection requiring
drainage, hyperbilirubinemia (7.0 mg/dl) bile leak, cholangitis,
ascites or liver failure.
Statistical analyses were performed with PASW version 18
(Chicago, IL, USA) software. For univariable and multivariable
analyses, diagnoses were grouped as benign, metastatic and
primary hepatobiliary malignancy. Data distribution was tested
for normality by examining the mean and standard error of the
kurtosis and skewness. Comparisons were performed using the
Mann–Whitney U- or Kruskal–Wallis tests for non-normally dis-
tributed continuous variables. c2 analyses were used for categori-
cal variable comparisons. Logistic regression was employed to test
predictors of morbidity and mortality. Predictors for each model
were chosen based on significant associations (P 0.05) between
the predictor and dependent variable using univariable analyses.
Results
Overall cohort
From 2002 to 2009, 1670 consecutive patients underwent a liver
resection at the Liver Cancer Center at UPMC or at DUMC. In all,
879 (52.6%) patients underwent resection at UPMC and most
patients at both centres were Caucasian (Table 1). 354 (21.9%)
underwent resection for benign disease and the most common
malignant indications for surgery included colorectal cancer
metastases, hepatocellular carcinoma and other metastatic disease
(Table 1) and 222 (13.3%) patients underwent laparoscopic resec-
tion. Simultaneous major non-hepatic procedures were per-
formed in 428 (25.6%) patients. Colorectal, diaphragm and bile
duct resections were the most commonly performed simulta-
neous procedures (Table 1). Most patients had an American
Society of Anesthesiology (ASA) score of II or III. The largest
component of each resection stratified by the total number of liver
segments resected is reported in Table 2. For example, a liver
resection encompassing a posterior sectionectomy and two left-
sided wedge resections would be categorized as a three segment
resection where the largest component of the resection was a
bisegmentectomy. In the entire cohort, post-operative mortality,
severe morbidity, overall morbidity and hepatic-related morbidity
occurred in 74 (4.4%), 496 (29.7%), 695 (41.6%) and 323 (19.3%)
patients, respectively.
Comparisons by extent of resection
In all, 814 (48.7%), 219 (13.1%) and 637 (38.1%) patients under-
went resection of two or less, three and four or more hepatic
segments, respectively. One hundred and fifty-three (9.1%)
patients underwent complete or wedge resections of the caudate
as a component of the overall hepatic resection. Twenty-one
(2.6%), 6 (2.7%), and 126 (19.8%) patients underwent caudate
resection among patients who underwent resection of two or
fewer, three and four or more liver segments. Patients who under-
went resection of four or more segments more often had a caudate
resection compared with three and two or fewer segments (P <
0.05). There were significant differences in patient age and ethnic-
ity between these groups (Table 1). Patients at DUMCmore often
underwent larger volume resections (particularly resection of
three liver segments) compared with those at UPMC. For themost
part, larger volume resections were more often performed for
malignant indications. As expected, laparoscopic resections com-
prising four ormore, three, and two or less segments were decreas-
ingly common. Rates of simultaneous non-hepatic procedures
were highest with resections encompassing four or more seg-
ments. Pre-operative albumin tended to be slightly higher among
patients undergoing resection of two or less segments (Table 1). In
spite of a similar median international normalized ratio (INR) for
each group, comparisons of the non-normal distributions of INR
between groups revealed statistical differences as a result of the
extremes at the upper end of each respective distribution.
Comparing all three groups, post-operative mortality (7.4% vs.
2.7% vs. 2.6%) and severe (36.7% vs. 24.7% vs. 24.1%), overall
HPB 495
HPB 2011, 13, 494–502 © 2011 International Hepato-Pancreato-Biliary Association
Table 1 Demographics, clinicopathological tumour characteristics, pre-operative laboratory values and surgical treatments stratified by
extent of hepatic resection
All patients
(n = 1670)
Two segments
(n = 814)
Three segments
(n = 219)
Four segment
(n = 637)
P
Age (years)* 59 (49–69) 58 (48–68) 62 (50–72) 59 (50–69) 0.013
Male gender 782 (47.5%) 413 (50.8%) 117 (53.4%) 346 (54.4%) 0.385
Ethnicity <0.001
Caucasian 1430 (86.7%) 690 (84.8%) 192 (87.7%) 548 (86.0%)
African–American 173 (10.5%) 86 (10.6%) 17 (7.8%) 70 (11.0%)
Asian 24 (1.5%) 13 (1.6%) 3 (1.4%) 8 (1.3%)
Hispanic 5 (0.3%) 4 (0.5%) 0 1 (0.2%)
Native American 7 (0.4%) 5 (0.6%) 2 (0.9%) 0
Other 10 (0.6%) 6 (0.7%) 1 (0.5%) 3 (0.5%)
NA 21 (1.3%) 10 (1.2%) 4 (1.8%) 7 (1.1%)
Institution <0.001
DUMC 791 (47.4%) 349 (49.2%) 144 (65.8%) 298 (53.2%)
UPMC 879 (52.6%) 465 (57.1%) 75 (34.2%) 339 (46.8%)
Diagnoses <0.001
Benign 354 (21.9%) 226 (27.8%) 44 (20.1%) 84 (13.5%)
Colorectal cancer metastases 624 (38.5%) 290 (35.6%) 55 (25.1%) 279 (43.8%)
Hepatocellular carcinoma 228 (14.1%) 113 (13.9%) 38 (17.4%) 77 (12.4%)
Other metastatic disease 224 (13.8%) 115 (14.1%) 20 (9.1%) 89 (14.3%)
Cholangiocarcinoma 121 (7.5%) 15 (1.8%) 32 (14.6%) 74 (11.6%)
Gallbladder carcinoma 57 (3.5%) 28 (3.4%) 16 (7.3%) 13 (2.1%)
Other primary malignancy 11 (0.7%) 3 (0.4%) 1 (0.5%) 7 (1.1%)
NA 51 (3.1%) 24 (2.9%) 13 (5.9%) 14 (2.2%)
Laparoscopic resection 222 (13.3%) 187 (23.0%) 25 (11.4%) 10 (1.6%) <0.001
Simultaneous non-hepatic procedures 428 (25.6%) 192 (23.6%) 48 (21.9%) 188 (29.5%) 0.024
Bile duct resection 117 (7.0%) 22 (2.7%) 27 (12.3%) 68 (10.7%)
Colorectal resection 113 (6.8%) 66 (8.1%) 6 (2.7%) 41 (6.4%)
Diaphragm resection 92 (5.5%) 44 (5.4%) 5 (2.3%) 43 (6.8%)
Upper gastrointestinal resection 58 (3.5%) 34 (4.2%) 5 (2.3%) 19 (3.0%)
Vascular resection and reconstruction 30 (1.8%) 4 (0.5%) 6 (2.7%) 20 (3.1%)
Pancreatic resection 16 (1.0%) 8 (1.0%) 1 (0.5%) 7 (1.1%)
Other 107 (6.4%) 63 (7.7%) 10 (4.6%) 34 (5.3%)
ASA Score 0.091
I 41 (2.6%) 25 (3.2%) 1 (0.5%) 15 (2.5%)
II 542 (34.1%) 285 (36.7%) 69 (33.5%) 188 (31.1%)
III 946 (59.6%) 441 (56.8%) 129 (62.6%) 376 (62.1%)
IV 59 (3.7%) 26 (3.3%) 7 (3.4%) 26 (4.3%)
NA 82 (4.9%) 37 (4.5%) 13 (5.9%) 32 (5.0%)
Pre-operative bilirubin (mg/dl)* 0.5 (0.3–0.7) 0.5 (0.3–0.7) 0.5 (0.3–0.8) 0.5 (0.3–0.7) 0.403
Pre-operative albumin (mg/dl)* 4.0 (3.7–4.3) 4.1 (3.7–4.4) 4.0 (3.6–4.3) 4.0 (3.7–4.3) 0.068
Pre-operative INR* 1 (1.0–1.1) 1.0 (1.0–1.1) 1.0 (1.0–1.1) 1.0 (1.0–1.1) 0.002
*Continuous variables are reported as median (25th–75th perecentiles).
NA, not applicable; ASA, American Society of Anesthesiology; INR, international normalized ratio.
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(49.3% vs. 40.6% vs. 35.9%), and hepatic relatedmorbidity (25.6%
vs. 16.4% vs. 15.2%) were all more common after resection of four
or more liver segments compared with three and two or fewer
segments (allP< 0.001).Rates of each endpointwere higher among
patients who underwent resection of four or more segments com-
pared with two or fewer segments (all P < 0.001). Similarly, rates of
all endpoints were all higher after resection of four or more seg-
ments compared with three segments (all P < 0.05), Fig. 1. In
contrast, no significant difference in each endpoint was observed
after resection of three and two or less segments.
Univariable and multivariable analyses
On univariable analysis, age greater than 50 years, male gender,
diagnosis, simultaneous non-hepatic procedure, laparoscopic
resection, ASA score, extent of resection, pre-operative albumin,
bilirubin and INR were all significantly associated with post-
operative mortality (Table 3). On multivariable analysis, male
gender, primary hepatobiliary malignancy, simultaneous non-
hepatic procedure, pre-operative albumin and resection of four or
more liver segments were all independently associated with post-
operative mortality (Table 4). Laparoscopic resection, diagnosis,
simultaneous non-hepatic procedure, ASA score, extent of resec-
tion, pre-operative albumin, bilirubin and INR were all signifi-
cantly associated with severe post-operative morbidity on
univariable analysis (Table 2). On multivariable analysis, primary
hepatobiliary malignancy, simultaneous non-hepatic procedure
and resection of four or more liver segments were all indepen-
dently associated with severe post-operative morbidity (Table 5).
Age greater than 50 years, male gender, diagnosis, simultaneous
non-hepatic procedure, laparoscopic resection, ASA score, extent
of resection, pre-operative albumin, bilirubin and INR were all
significantly associated with overall post-operative morbidity on
univariable analysis (Table 2). On multivariable analysis, age
greater than 50 years, primary hepatobiliary malignancy, laparo-
Table 2 Surgical treatments stratified by total number of segments
resected. The largest component of each liver resection is reported
Total (n = 1670)
Four or more hepatic segments
Extended right hepatectomy 139 (8.3%)
Extended left hepatectomy 58 (3.5%)
Right hepatectomy 420 (25.1%)
Left hepatectomy 20 (1.2%)
Three hepatic segments
Left hepatectomy 167 (10.0%)
Central liver resection 41 (2.5%)
Bisegmentectomy 11 (0.7%)
Two or fewer hepatic segments
Bisegmentectomy 529 (31.7%)
Monosegmentectomy 53 (3.2%)
Wedge resection 225 (13.5%)
Miscellaneous 7 (0.4%)
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Figure 1 Post-operative mortality and severe, overall, and hepatic morbidity by extent of resection. No significant difference in each endpoint
was observed after resection of three and two or fewer liver segments. *P < 0.05 compared with three liver segments and two or less
liver segments
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scopic liver resection, simultaneous non-hepatic procedure, ASA
score of II (relative to I) and resection of four or more liver
segments was independently associated with overall post-
operative morbidity (Table 6). Male gender, site of liver resection,
diagnosis, laparoscopic resection, simultaneous non-hepatic pro-
cedure, ASA score, extent of resection, pre-operative albumin,
bilirubin and INR were all significantly associated with hepatic-
related post-operative morbidity on univariable analysis
(Table 2). On multivariable analysis, male gender, site of liver
resection, primary hepatobiliary malignancy, simultaneous non-
hepatic procedure, pre-operative bilirubin and resection of four
or more liver segments were independently associated with
hepatic-related post-operative complications (Table 7).
Discussion
Remnant liver volume is widely considered the key factor in pre-
dicting complications after a partial hepatectomy. As this mea-
Table 3 Univariable analysis for mortality, severe morbidity, overall morbidity, cardiopulmonary morbidity and hepatic morbidity
Mortality Severe morbidity Overall morbidity Hepatic morbidity
P P P P
Age <0.001 0.083 <0.001 0.216
50 years (n = 489) 7 (1.4%) 130 (26.5%) 172 (35.2%) 85 (17.4%)
>50 years (n = 1181) 67 (5.7%) 366 (31.0%) 523 (44.3%) 238 (20.2%)
Gender <0.001 0.767 <0.001 <0.001
Male (n = 876) 52 (6.6%) 229 (29.3%) 369 (47.2%) 180 (23.0%)
Female (n = 792) 22 (2.5%) 265 (30.1%) 325 (36.6%) 143 (16.1%)
Ethnicity 0.198 0.921 0.290 0.769
Caucasian (n = 1430 ) 60 (4.2%) 429 (30.0%) 595 (41.6%) 278 (19.4%)
Non-Caucasian (n = 219) 14 (6.3%) 61 (30.6%) 100 (45.7%) 45 (20.5%)
Institution 0.712 0.827 0.174 0.004
UPMC (n = 791) 33 (4.2%) 237 (29.9%) 315 (39.8%) 129 (16.3%)
Duke (n = 879) 41 (4.7%) 258 (29.4%) 380 (43.2%) 194 (22.1%)
Diagnosis <0.001 <0.001 <0.001 <0.001
Benign (n = 354) 2 (0.6%) 76 (21.5%) 117 (33.1%) 52 (14.7%)
Primary malignant (n = 417) 45 (10.8%) 170 (40.7%) 255 (61.2%) 141 (33.8%)
Metastatic disease (n = 848) 27 (3.2%) 240 (28.3%) 323 (38.1%) 130 (15.3%)
Laparoscopic resection 0.021 <0.001 <0.001 0.050
Yes (n = 222) 3 (1.4%) 43 (19.4%) 59 (26.6%) 32 (14.4%)
No (n = 1448) 71 (4.9%) 453 (31.3%) 636 (43.9%) 291 (20.1%)
Simultaneous procedures <0.001 <0.001 <0.001 <0.001
Yes (n = 428) 37 (8.6%) 180 (42.1%) 238 (55.6%) 124 (29.0%)
No (n = 1242) 37 (3.0%) 316 (25.4%) 457 (36.8%) 199 (16.0%)
ASA Score <0.001 <0.001 <0.001 <0.001
I (n = 41) 1 (2.4%) 7 (17.1%) 11 (26.8%) 5 (12.2%)
II (n = 542) 8 (1.5%) 132 (24.4%) 191 (35.2%) 85 (15.7%)
III (n = 946) 52 (5.5%) 304 (32.1%) 425 (44.9%) 189 (20.0%)
IV (n = 59) 9 (15.3%) 28 (47.5%) 37 (62.7%) 30 (50.8%)
Extent of resection <0.001 <0.001 <0.001 <0.001
2 segments (n = 814) 21 (2.6%) 196 (24.1%) 292 (35.9%) 124 (15.2%)
3 segments (n = 219) 6 (2.7%) 65 (24.7%) 89 (40.6%) 36 (16.4%)
4 segments (n = 637) 47 (7.4%) 235 (36.9%) 314 (49.3%) 163 (25.6%)
Pre-operative bilirubin (mg/dl)* 0.7 vs. 0.5 <0.001 0.5 vs. 0.5 <0.001 0.5 vs. 0.5 <0.001 0.6 vs. 0.5 <0.001
Pre-operative albumin (mg/dl)* 3.7 vs. 4.0 <0.001 4.1 vs. 3.9 <0.001 3.9 vs. 4.1 <0.001 3.9 vs. 4.1 <0.001
Pre-operative INR* 1.1 vs. 1.0 <0.001 1.0 vs. 1.0 <0.001 1.0 vs. 1.0 0.002 1.0 vs. 1.0 0.002
*Medians are reported for continuous variable comparisons.
ASA, American Society of Anesthesiology; INR, international normalized ratio.
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surement is difficult, inconsistent and unreported in most
resection series, extent of resection is used as a surrogate for
remnant liver volume. In the present study of a large series of
liver resections for a wide variety of indications at two high
volume academic centres, resection of four or more liver seg-
ments was independently associated with post-operative mortal-
ity and severe, overall and hepatic-related morbidity.
Importantly, this finding was independent of other factors
expected to increase mortality and morbidity risk, including
primary hepatobiliary malignancy, simultaneous non-hepatic
procedures, advanced patient age and ASA score. In contrast,
there were no differences in post-operative outcomes after resec-
tion of three and two or less liver segments. Therefore, in the
modern era of enhanced anaesthetic and critical care, a better
understanding of hepatic segmental anatomy and improved
transection techniques, a standard left hepatectomy (resection of
three segments using Brisbane criteria) should not be considered
a major hepatic resection. These results are in accordance to that
reported by Aloia et al.15 who analysed 2313 hepatic resections in
the National Surgical Quality Improvement Program dataset
from 2005–2007. Rates of all categories of severe morbidity were
similar after a left hepatectomy (a three segment resection) com-
pared with after a lesser hepatectomy. In contrast, severe mor-
bidity was higher after a right and extended hepatectomy.
Thirty-day post-operative mortality after a lesser, left, right and
extended hepatectomy were 1.8%, 0.9%, 3.7% and 5.2%, respec-
Table 4 Multivariable analysis for post-operative mortality
Beta Odds ratio 95% CI P
Age greater than 50 years 1.026 2.789 0.980–7.939 0.055
Male gender 1.142 3.133 1.681–5.837 <0.001
Diagnosis (ref: Benign)
Primary hepatobiliary malignancy 1.123 3.073 1.684–5.607 <0.001
Metastatic disease -0.540 0.582 0.125–2.711 0.491
Laparoscopic resection 0.069 1.071 0.301–3.809 0.916
Simultaneous non-hepatic procedure 0.651 1.918 1.066–3.453 0.030
ASA score (ref: I)
II -0.338 0.713 0.064–7.907 0.783
III -0.899 0.407 0.043–3.870 0.434
IV -1.588 0.204 0.020–2.057 0.178
Pre-operative bilirubin 0.067 1.070 0.870–1.315 0.523
Pre-operative albumin -0.806 0.447 0.284–0.702 <0.001
Pre-operative INR 0.151 1.163 0.330–4.099 0.815
Four or more liver segment resection 0.941 2.561 1.424–4.606 0.002
ASA, American Society of Anesthesiology; INR, international normalized ratio.
Table 5 Multivariable analysis for severe post-operative morbidity
Beta Odds ratio 95% CI P
Diagnosis (ref: Benign)
Primary hepatobiliary malignancy 0.571 1.770 1.335–2.347 <0.001
Metastatic disease 0.173 1.188 0.825–1.713 0.355
Laparoscopic resection 0.229 1.257 0.815–1.940 0.301
Simultaneous non-hepatic procedure 0.707 2.027 1.550–2.652 <0.001
ASA (ref: I)
II 1.119 3.061 0.950–9.859 0.061
III 0.859 2.360 0.866–6.431 0.093
IV 0.578 1.783 0.653–4.869 0.259
Pre-operative bilirubin 0.054 1.055 0.916–1.216 0.454
Pre-operative albumin 0.192 1.212 0.583–2.518 0.606
Pre-operative INR -0.164 0.849 0.678–1.062 0.152
Four or more liver segment resection 0.496 1.642 1.281–2.104 <0.001
ASA, American Society of Anesthesiology; INR, international normalized ratio.
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tively. The extent of a hepatic resection was associated with
severe morbidity (OR 1.8, P = 0.0001) but not mortality.
Results of the present study have several implications for the
field of hepatobiliary surgery.Although less commonly performed
compared with resection of four or more and two or fewer liver
segments, a three-segment hepatic resection (particularly a left
hepatectomy) is a standard partial hepatectomy that has been
regarded by many surgeons as a major liver resection.2,5,6,8,20,25,36,37
Yet the pesent study demonstrates higher relative risks of post-
operative mortality (174.1%), severe morbidity (48.5%), overall
morbidity (21.4%) and hepatic-related morbidity (56.1%) after
resection of four or more segments relative to after resection of
three segments. Moreover, there was no significant difference in
post-operative outcomes after resection of three and two or fewer
segments. An established definition of a major hepatectomy as
resection of four or more segments allows for accurate compari-
son of post-operative outcomes between resection series. Novel
surgical approaches, transection techniques, and intra-operative
Table 6 Multivariable analysis for overall post-operative morbidity
Beta Odds ratio 95% CI P
Male gender 0.189 1.207 0.914–1.595 0.184
Age greater than 50 years 0.308 1.361 1.083–1.710 0.008
Diagnosis (ref: Benign)
Primary hepatobiliary malignancy 0.593 1.809 1.382–2.367 <0.001
Metastatic disease 0.309 1.362 0.969–1.915 0.075
Laparoscopic resection 0.445 1.560 1.060–2.295 0.024
Simultaneous non-hepatic procedure 0.684 1.981 1.529–2.568 <0.001
Pre-operative bilirubin 0.133 1.142 0.977–1.335 0.096
Pre-operative albumin -0.175 0.840 0.679–1.039 0.108
Pre-operative INR -0.138 0.871 0.434–1.749 0.698
ASA (ref: I)
II 1.063 2.895 1.029–8.143 0.044
III 0.575 1.778 0.777–4.069 0.173
IV 0.328 1.389 0.611–3.155 0.433
Four or more liver segment resection 0.425 1.530 1.213–1.929 <0.001
ASA, American Society of Anesthesiology; INR, international normalized ratio.
Table 7 Multivariable analyses for hepatic related post-operative morbidity
Beta Odds ratio 95% CI P-value
Male gender 0.377 1.458 1.092–1.946 0.011
Resection at UPMC 0.342 1.408 1.049–1.889 0.023
Diagnosis (ref: Benign)
Primary hepatobiliary malignancy 0.721 2.057 1.489–2.843 <0.001
Metastatic disease 0.225 1.252 0.808–1.939 0.314
Laparoscopic resection -0.289 0.749 0.454–1.236 0.258
Simultaneous non-hepatic procedure 0.566 1.762 1.288–2.410 <0.001
ASA (ref: I)
II 0.656 1.926 0.583–6.366 0.282
III 0.133 1.142 0.414–3.149 0.797
IV -0.043 0.958 0.346–2.648 0.934
Pre-operative bilirubin 0.190 1.209 1.041–1.403 0.013
Pre-operative albumin -0.172 0.842 0.649–1.093 0.197
Pre-operative INR -0.296 0.744 0.302–0.835 0.521
Four or more liver segment resection 0.691 1.996 1.491–2.672 <0.001
UPMC, University of Pittsburgh Medical Center; ASA, American Society of Anesthesiology; INR, international normalized ratio.
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and post-operative treatments aimed at improving the safety
profile of a partial hepatectomy should focus on those patients
undergoing resection of at least four liver segments as these
patients are at highest risk of post-operative morbidity and mor-
tality. This criterion for major hepatic resection also allow for a
more precise estimate of post-operative risk when counselling
patients regarding liver resection.
Several limitations to the present study should be considered.
Although pre-operative synthetic liver function (as measured by
plasma albumin, bilirubin and INR) was recorded, chemotherapy
associated liver disease, non-alcoholic fatty liver disease, fibrosis
and cirrhosis were not directly accounted for in the present
study. Thus, our conclusions may not apply in cases of severe
liver disease where even low volume liver resections can have
deleterious consequences. Disease in the non-tumour bearing
liver (such as cirrhosis and cholestatic jaundice in the settings of
hepatocellular carcinoma and extrahepatic cholangiocarcinoma,
respectively) is probably the rationale why primary hepatobiliary
malignancy was independently associated with poor post-
operative outcomes. Because specific comorbidity data were not
available for each patient, more accurate gauges of comorbidity,
such as the Charleson comorbidity index, could not be calcu-
lated. We aimed to identify predictors of poor post-operative
outcome based on pre-operatively identified factors. Thus intra-
operative and post-operative variables, such as estimated blood
loss and blood transfusion, which may worsen outcomes, were
not accounted for in the present study. Several limitations owing
to the retrospective nature of this study must be acknowledged.
Retrospective data retrieval prevented verification that an
assigned morbidity met the accepted published criteria for that
particular complication when such a criteria exists. We relied
upon individual physician interpretation of post-operative com-
plications described in the medical record. Accurate assessments
of wedge resection volume were unobtainable in this retrospec-
tive study. Because any nonanatomic resection was classified as a
wedge resection (encompassing 0.5 segments), the amount of
liver resected among those who underwent resection of two or
fewer segments may have been underestimated. In spite of this
potential bias, post-operative outcomes were no different com-
pared with three-segment resections and were superior com-
pared with resection of four or more liver segments. Multiple
resections of separate segments and technically challenging resec-
tions (such as those involving the posterior sector) may be asso-
ciated with worse post-operative outcomes regardless of the total
number of segments resected. Thus all three and two or fewer
segment resections may not have similar post-operative out-
comes. By increasing the volume of the anticipated liver remnant,
pre-operative portal vein embolization may improve post-
operative outcomes after large volume liver resections.38,39 While
used relatively infrequently before resections of four or more
liver segments in this series, we did not account for this factor in
our analyses. Liver volumetry using pre-operative imaging was
not routinely performed before liver resection at either institu-
tion. These measurements were not available for the vast major-
ity of patients who underwent liver resection at these two centres.
All of these details were not accounted for in the present study
and thus are important limitations to the applicability of the
present results.
A major hepatectomy should be defined as resection of four or
more liver segments. Studies evaluating post-operative outcomes
and novel treatments aimed at improving the safety profile of a
partial hepatectomy should focus on patients undergoing resec-
tion of four or more liver segments.
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